Menu Search
Equities

Alphatec Holdings Inc

ATEC:NSQ

Alphatec Holdings Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)9.15
  • Today's Change-0.135 / -1.45%
  • Shares traded2.26m
  • 1 Year change-8.00%
  • Beta1.3434
Data delayed at least 15 minutes, as of Nov 13 2024 20:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Alphatec Holdings Inc had net income fall 23.36% from a loss of 151.29m to a larger loss of 186.64m despite a 37.45% increase in revenues from 350.87m to 482.26m. An increase in the cost of goods sold as a percentage of sales from 33.58% to 35.68% was a component in the falling net income despite rising revenues.
Gross margin69.47%
Net profit margin-31.06%
Operating margin-27.44%
Return on assets-25.12%
Return on equity--
Return on investment-32.00%
More ▼

Cash flow in USDView more

In 2023, Alphatec Holdings Inc increased its cash reserves by 160.90%, or 136.27m. Cash Flow from Financing totalled 356.92m or 74.01% of revenues. In addition the company used 78.49m for operations while cash used for investing totalled 141.98m.
Cash flow per share-0.737
Price/Cash flow per share--
Book value per share0.1546
Tangible book value per share-1.04
More ▼

Balance sheet in USDView more

Alphatec Holdings Inc has a Debt to Total Capital ratio of 95.96%.
Current ratio2.32
Quick ratio1.15
Total debt/total equity23.73
Total debt/total capital0.9596
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.